Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma  Ashlyn S. Everett, MD, Bradford S. Hoppe, MD,

Published byAureliana Martina Modified over 5 years ago

Similar presentations

Presentation on theme: "Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma  Ashlyn S. Everett, MD, Bradford S. Hoppe, MD,"— Presentation transcript:

1 Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma  Ashlyn S. Everett, MD, Bradford S. Hoppe, MD, MPH, Debbie Louis, CMD, Andrew M. McDonald, MD, MS, Christopher G. Morris, MS, Nancy P. Mendenhall, MD, Zuofeng Li, DSc, Stella Flampouri, PhD  Practical Radiation Oncology  Volume 9, Issue 6, Pages (November 2019) DOI: /j.prro Copyright © 2019 The Author(s) Terms and Conditions

2 Figure 1 Median cumulative dose-volume histogram for the 21 patients studied with each treatment modality. Practical Radiation Oncology 2019 9, DOI: ( /j.prro ) Copyright © 2019 The Author(s) Terms and Conditions

3 Figure 2 Colorwash dose distribution for a representative patient showing (A) free-breathing intensity modulated radiation therapy, (B) free-breathing proton therapy, (C) deep inspiration breath-hold intensity modulated radiation therapy, and (D) deep-inspiration breath-hold proton therapy (Image borrowed with permission from Hoppe et al.38). Practical Radiation Oncology 2019 9, DOI: ( /j.prro ) Copyright © 2019 The Author(s) Terms and Conditions

Download ppt "Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma  Ashlyn S. Everett, MD, Bradford S. Hoppe, MD,"

Similar presentations

Corresponding author Name; 2015 North Jefferson St; 904-588- 1800 Three-Year Analysis of Urinary Toxicity in Two Prospective Trials.

Corresponding author Name; 2015 North Jefferson St; Three-Year Analysis of Urinary Toxicity in Two Prospective Trials.
Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Adaptation of the Stanford technique for treatment of bulky cutaneous T-cell lymphoma of the head  Safia K. Ahmed, MD, Michael P. Grams, PhD, Sarah E.

Adaptation of the Stanford technique for treatment of bulky cutaneous T-cell lymphoma of the head  Safia K. Ahmed, MD, Michael P. Grams, PhD, Sarah E.
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.
Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.

Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.
Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J

Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J
Should we irradiate a brain tumor in a patient with parkinsonism

Should we irradiate a brain tumor in a patient with parkinsonism
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.
A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs  Charles E. Argoff,

A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs  Charles E. Argoff,
Volume 15, Issue 10, Pages (September 2014)

Volume 15, Issue 10, Pages (September 2014)
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Similar presentations

Ads by Google